EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Review

What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?

Altay Çelebi ¹ , Hasan Yılmaz ¹

Author Affiliation(s)

1.

Department of Gastroenterology, Kocaeli University School of Medicine, Kocaeli, Turkey

Turk J Gastroenterol 2017; 28: Supplement S71-S72

DOI: 10.5152/tjg.2017.18

Keywords : Proton pump inhibitors, drug therapy, gastroesophageal reflux desease

Read: 1634 Downloads: 849 Published: 25 July 2019

Volume 28, Issue 1, November 2017

Previous Article

Abstract

Proton pump inhibitors become the most potent therapeutic option in gastroesophageal reflux disease. Unresponsiveness to this treatment is not uncommon in clinical practice. We reviewed the definition of PPI unresponsiveness and the management of this situation.

Cite this article as: Çelebi A, Yılmaz H. What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed? Turk J Gastroenterol 2017;28(Suppl 1); S71-S72

Full Text Turkish

Files